Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)

Ozkan M., Cicin I., Ozaslan E., Benekli M., Oksuzoglu B., Kocer M., ...Daha Fazla

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51 identifier